Cargando…
Chemoinformatic Design and Profiling of Derivatives of Dasabuvir, Efavirenz, and Tipranavir as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase and Methyltransferase
[Image: see text] Zika virus (ZIKV) infection is one of the mosquito-borne flaviviruses of human importance with more than 2 million suspected cases and more than 1 million people infected in about 30 countries. There are reported inhibitors of the zika virus replication machinery, but no approved e...
Autores principales: | Ezeh, Madeleine I., Okonkwo, Onyinyechi E., Okpoli, Innocent N., Orji, Chima E., Modozie, Benjamin U., Onyema, Augustine C., Ezebuo, Fortunatus C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494688/ https://www.ncbi.nlm.nih.gov/pubmed/36157724 http://dx.doi.org/10.1021/acsomega.2c03945 |
Ejemplares similares
-
FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
por: Stefanik, Michal, et al.
Publicado: (2020) -
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir
por: Song, Ivy, et al.
Publicado: (2014) -
Tipranavir in the Protease Inhibitors Arena
por: Vergani, Barbara, et al.
Publicado: (2012) -
Review of tipranavir in the treatment of drug-resistant HIV
por: Streeck, Hendrik, et al.
Publicado: (2007) -
Role of tipranavir in treatment of patients with multidrug-resistant HIV
por: Courter, Joshua D, et al.
Publicado: (2010)